Introduction
Signal transduction in response to a variety of extracellular stimuli involves the early and rapid participation of Ras proteins (Downward, 1996; Yan et al., 1998; Olson and Marais, 2000; Shields et al., 2000) . In turn, the members of the Ras superfamily bind to and activate protein targets that are engaged in at least three downstream pathways: the Ral-specific guanine nucleotide exchange factors, the phosphatidylinositol 3-kinase (PI3-kinase), and the Raf-1 kinase (Lander et al., 1995; Downward, 1996; Folgueira et al., 1996; Fenwick et al., 2000; Henry et al., 2000; Shields et al., 2000) . Biochemical and genetic studies suggest that the different Ras isoforms mediate distinct and in part nonoverlapping biological effects. In support of a nonredundant role of the Ras proteins is their specific requirement at different levels during development (Umanoff et al., 1995; Johnson et al., 1997) . Moreover, the physical localization of the Ras isoforms in the plasma membrane is different. The palmitoylation and farnesylation of N-Ras and H-Ras in the C-terminal cysteines direct the proteins from the endoplasmic reticulum towards the plasma membrane through the well-established exocytic pathway, whereas K-Ras, because of the lack of these modifications is translocated to the plasma membrane through a poorly characterized mechanism (Choy et al., 1999; Prior and Hancock, 2001) . Once in the membrane, the microenvironments where the Ras isoforms are localized appear to be relevant for their biological activity (Prior and Hancock, 2001) . For example, it has been described that K-Ras is a potent activator of Raf-1 and a poor activator of the PI3-kinase pathway, whereas H-Ras exhibits the opposite effect (Yan et al., 1998) . The regions of interaction of Ras with the effector proteins are located at the conserved N-terminal domains and, therefore, this cannot explain the specific effects of the Ras proteins. Indeed, it appears that specificity relays on motifs present in the C-terminal domain of Ras. In this regard, it has been shown that H-Ras is associated to lipid rafts and caveoli, and K-Ras is located outside the rafts, both exhibiting different susceptibilities to redistribution in membrane microdomains upon activation (Prior and Hancock, 2001 ).
Several groups have described that Ras signaling influences the NF-kB pathway to different extents, either increasing (Folgueira et al., 1996; Finco et al., 1997; Norris and Baldwin, 1999; Arsura et al., 2000; Fenwick et al., 2000; Jo et al., 2000) or repressing (Cadoret et al., 1997; Pahan et al., 2000; Fritz and Kaina, 2001 ) its activity, although a systematic study on the effect of the distinct isoforms of Ras on the activation of NF-kB has not been undertaken. The transcription factor NF-kB integrates the response to different signaling pathways and is involved in the regulation of the expression of genes that participate in the inflammatory onset, cell proliferation and suppression of apoptosis (May and Ghosh, 1998; Delhase et al., 1999; Karin, 1999) . The activation of NF-kB requires phosphorylation by IkB kinase (IKK) of IkB proteins in specific serine residues that target these proteins for ubiquitin conjugation and degradation by the 26S proteasome (DiDonato et al., 1997; Delhase et al., 1999) . The IKK complex contains two catalytic subunits, IKK1 and IKK2, and a regulatory subunit termed NF-kB Essential Modulator (NEMO). The activation of IKK is mediated by phosphorylation through NF-kB -inducing kinase (NIK), which targets preferentially IKK1, and MEKK1 that phosphorylates IKK2 (Lee et al., 1998; Karin, 1999) .
Since NF-kB activation interferes with apoptotic signaling through different mechanisms (De Smaele et al., 2001; Madrid et al., 2000; Mayo et al., 2001; Tang et al., 2001) , this pathway contributes to enhance cell viability. In this work, we have investigated whether the ectopic expression of each Ras isoform influences the activation of NF-kB in NIH3T3 cells. Treatment of cells with TNFa has been used to evaluate whether the expression of the distinct Ras proteins affects the activation of the NF-kB pathway. Among the biological processes regulated by Ras and dependent on NF-kB activity, we investigated the sensitivity of cells to experience staurosporine-induced apoptosis and whether the Ras proteins could modulate this process. Our data showed that overexpression of H-Ras results in a significant increase of NF-kB basal activity that renders the cells more resistant to staurosporine-induced apoptosis, therefore enhancing cell viability.
Results

Effect of Ras isoforms on basal and TNFa-induced NFkB activation
The ability of TNFa to activate NF-kB in cells overexpressing H-Ras, K-Ras and N-Ras was evaluated by measuring the binding of nuclear protein extracts to a kB motif using electrophoretic mobility shift assays (EMSAs). As Figure 1a shows, a similar time-dependent activation of NF-kB was observed in all cases, with a maximal activation at 0.5 h followed by a decrease in the band intensity of the EMSA. Supershift analysis, using specific anti-p50, -p65 and c-Rel antibodies (not shown), indicated that the upper complex (main band) contained p50 and p65 heterodimers, and the lower band corresponded to p50 homodimers. However, it was systematically noted that cells expressing H-Ras exhibited a basal NF-kB activity that represented ca. 40% of the p50/p65 band intensity measured 30 min after TNFa activation. This was not the case of K-Ras and N-Ras that failed to promote by itself a significant NF-kB activation. This basal activation of NF-kB was confirmed in at least three distinct clones overexpressing HRas, but not with K-Ras or N-Ras. The cytosolic levels of IKK1/2, p65 and IkBa from the NF-kB pathway, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and AU5 as control of the protein charge in the blots and Ras expression, respectively, were determined. To gain insight into the mechanism of NF-kB activation by H-Ras, the IKK complex was immunoprecipitated from cell extracts and the activity was assayed in vitro using myelin basic protein (MBP) and GST-IkBa as substrates. As Figure 1c shows, a statistically significant IKK activity was observed in cells expressing H-Ras, and a further increase was measured after stimulation with TNFa. Similar results were obtained when the assay was performed with the more specific substrate GST-IkBa, following the phosphorylation in serine 32 with a specific antibody ( Figure 1d ).
In addition to these experiments, the ability of the H-Ras, K-Ras and N-Ras proteins to activate an NF-kB -dependent reporter gene was investigated. After cotransfection of cells with a kB-luciferase vector and increasing amounts of Ras, a dose-response effect was observed in cells expressing H-Ras whereas cells transfected with high amounts of K-Ras or N-Ras exhibited a moderate luciferase activity ( Figure 2a) . Treatment of cells with TNFa enhanced specifically the reporter activity to similar levels regardless the Ras isoform expressed (Figure 2b ), which suggests that the NF-kB pathway remains unaltered despite the expression of these Ras proteins.
H-Ras activation of NF-kB protects against apoptosis
Since NF-kB activation has been shown to protect cells from stimulus-dependent apoptosis (Wang et al., 1998; Tang et al., 2001) , we investigated whether this could be a mechanism to increase cell survival in cells overexpressing Ras. To evaluate this possibility, we incubated cells expressing the different Ras isoforms in the absence or presence of TNFa in order to activate NFkB, and then induced apoptosis with staurosporine, the mechanism of action of which has been studied in previous works (Maeno et al., 2000; Hortelano et al., 2002) . As Figure 3a shows, H-Ras protected cells from staurosporine-induced apoptosis when compared with cells carrying the AU5 vector or expressing K-Ras and N-Ras. Incubation of cells with TNFa exerted a significant protection against staurosporine-induced apoptosis regardless of the Ras protein expressed. When the activation of NF-kB was impaired after pretreatment of the cells with the NF-kB translocation inhibitor SN50 (Lin et al., 1995) , the protective effect of H-Ras against staurosporine-induced apoptosis was lost. SN50 also abrogated the protective effect of TNFa treatment against staurosporine-induced apoptosis. Interestingly, this apoptosis was prevented by the broad caspase inhibitor z-VAD.fmk. Similar results were obtained when cells were treated with MG132, an inhibitor of the proteasome activity (not shown; see Figure 4 ), and therefore of NF-kB activation. Previous work showed that in intestinal epithelial cells inhibitors of both MEK1/ERK and NF-kB activation cooperate to induce apoptosis in response to TNFa through a mechanism dependent on kinase suppressor of Ras (KSR) (Yan et al., 2001) . At the same time, the contribution of the PI3-kinase/PKB to inhibit apoptosis has been well documented (Grana et al., 2002) . For these reasons, we investigated the relative contribution of these pathways to apoptosis in cells overexpressing Ras proteins. As Figure 3b shows, inhibition of MEK1 with PD98059 or PI3-kinase with LY294002 exerted a moderate increase in the basal apoptotic rate (less than 20% of the cells), especially when combined with SN50. When cells were treated with TNFa, the inhibition of NF-kB was clearly the main contributor to apoptosis and inhibition of MEK1 or PI3-kinase represented ca. 50% of the apoptosis observed with SN50. Interestingly, treatment with two inhibitors did not cooperate to increase the percentage of apoptotic cells, at least at the times analysed (24 h). When cells were treated with staurosporine, the main protection was observed in cells expressing H-Ras since only SN50 treatment enhanced notably apoptosis. Taken together, these results suggest that the basal activation of NF-kB promoted by H-Ras in these cells enhances cell survival. To better characterize the protection exerted by NFkB against apoptosis, the activation of caspase 3, an executioner caspase, was measured in extracts from cells treated with TNFa and staurosporine. Figure 4a shows the time course of DEVDase activity from cells treated with TNFa, staurosporine or both. Activation of caspase 3 was observed after 4 h of treatment with 100 nm staurosporine and was threefold higher in cells transfected with the AU5 vector or N-Ras than in HRas cells that exhibited a basal NF-kB activity. When cells were treated with TNFa the increase of caspase-3 activity was impaired and this cytokine protected Staurosporine-dependent DEVDase activation in cells expressing distinct Ras isoforms. NIH3T3 cells overexpressing the AU5 control (vector) or the indicated Ras isoforms were incubated for 2 h with 10 ng/ml of TNFa and then treated with 100 nm staurosporine and the DEVDase activity was measured at the indicated times using a fluorogenic substrate (a). The dose-dependent effect of staurosporine on DEVDase activity was determined in extracts from cells treated for 4 h with the indicated concentrations of staurosporine and that were previously preincubated (2 h) with TNFa and (5 h) with 10 mm of the proteasome inhibitor MG132
(b). Results show the mean of four experiments
Ras specificity in NF-jB activation O. Millán et al significantly from the apoptosis induced by 100 nm staurosporine. The dose-dependent effect of staurosporine on DEVDase activation was analysed at 4 h, and it was noted that the protection by TNFa was important at low (below 100 nm), but not at high concentrations of staurosporine (Figure 4b ). Indeed, treatment of H-Ras cells with 50 nm staurosporine failed to increase the DEVDase activity, whereas ca. 50% of the maximal activation was observed in cells expressing the AU5 tag or N-Ras. Treatment of cells with MG132 abolished the protection observed in cells overexpressing H-Ras, suggesting that the basal activity of NF-kB was involved in this effect.
Discussion
In this work, we compared the ability of the distinct Ras isoforms to activate NF-kB, and investigated whether this pathway influenced the fate of the cell in response to an apoptogenic stimulus. It is to be noted that the levels of Ras reached after ectopic expression are clearly supraphysiological. We have evaluated by Western blot analysis that the amount of AU5-Ras was ca. four times higher than the endogenous Ras (data not shown). Under these conditions, the basal activity of H-Ras, but not that of K-Ras or N-Ras was sufficient to activate significantly NF-kB. Interestingly, all three nononcogenic Ras isoforms did not modify the maximal NF-kB activation observed in response to a saturating concentration of TNFa, despite the distinct basal activities. The activation of NF-kB by H-Ras overexpression has been confirmed by different criteria including an increase in the activity of IKK, the binding of nuclear proteins to a kB motif, and the ability to express an NFkB-dependent reporter gene upon transfection. These data indicate the occurrence of a moderate constitutive activation of NF-kB, and a similar case has been described in other cases such as in the C-cell carcinoma transformed with mutated RET proto-oncogene (Ludwig et al., 2001) . The question of the biologically nonredundant specificity of the different Ras isoforms has been addressed by combining distinct strategies and it has been shown that these properties are mainly based on the selective distribution of the Ras members in the membrane (Prior and Hancock, 2001) . Moreover, Ras signaling involves several pathways where crosstalk, recruitment of cellular effectors and feedback loops cannot be disregarded (Campbell et al., 1998) . In this vein, the pathways involved in the activation of NF-kB by oncogenic Ras have been characterized previously and include both Raf-1-dependent and -independent mechanisms (Norris and Baldwin, 1999) . Indeed, the ability of H-RasV12 and Raf-1 to activate NF-kB was described previously in experiments of transfection using a kB-dependent reporter gene (Finco and Baldwin, 1993; Norris and Baldwin, 1999) . In addition to this, it has been shown that NF-kB activation was required for focus formation (Finco et al., 1997) , and for apoptosis inhibition (Mayo et al., 1997 (Mayo et al., , 2001 Baldwin, 2001) .
In this work, we have analysed the protective mechanisms of the Ras isoforms against apoptosis. Cells overexpressing H-Ras were protected against staurosporine-induced apoptosis through a mechanism that involves a moderate but sustained NF-kB activation, since this effect was abrogated after inhibition of NF-kB with SN50 or MG132. Inhibition of MEK1 or PI3-kinase failed to induce a significant apoptosis in response to TNFa or to cooperate with SN50-or staurosporine-induced apoptosis. This was not the case of epithelial cells where a cooperative response was observed between the NF-kB and MEK1 pathways (Yan et al., 2001) . In addition to these pathways, it has been described that early activation of caspases can cleave targets that act in turn as antiapoptotic molecules. For example, in the model of cisplatin-induced apoptosis, the cleavage of RasGAP after a moderate activation of caspase-9 renders a fragment that antagonizes caspase-9 activity and prevents apoptotic death. However, after full activation of caspase 9, other RasGAP fragments are generated and the protection is abrogated (McFall et al., 2001) . Moreover, stimulation of JNK has been shown to promote apoptosis in the absence of NF-kB activity (De Smaele et al., 2001; Tang et al., 2001) . JNK is activated in NIH3T3 cells transformed with Ras through a mechanism dependent on Raf, and requiring the release of endocrine factors (McCarthy et al., 1995; Norris and Baldwin, 1999) . In fact, ERK is stimulated rapidly after Raf activation, whereas JNK activity appears several hours after ERK. Therefore, the possibility exists that the persistent activation of NF-kB might contribute to prevent the apoptosis dependent on JNK, as described in other cell types (Tang et al., 2001) . Indeed, our data suggest that this basal NF-kB activity prevented the apoptosis induced by staurosporine. In summary, our data show a mechanism of desensitization of cells against apoptotic death that is dependent on the sustained NF-kB activity that follows H-Ras activation or overexpression. The potential contribution of this improvement of cell viability to favor cell proliferation and transformation cannot be disregarded.
Materials and methods
Chemicals
TNFa was from Roche (Mannheim, Germany). Protein-kinase inhibitors were from Calbiochem (San Jose, CA, USA). Anti-AU5 mAb was from Babco (Berkeley, CA, USA), antiphospho-S 32 -IkBa Ab was from New England Biolabs (Beverly, MA, USA) and other antibodies (IKK2, sc-7607; IKK1, sc 7218; IkBa, sc 371; p65, sc109) and GST-IkBa were from Santa Cruz Laboratories (Santa Cruz, CA, USA). TUNEL reagents (terminal deoxynucleotidyltransferasemediated dUTP-fluorescein nick end-labeling) were from Roche. Electrophoresis equipment and reagents were from Bio-Rad (Hercules, CA, USA).
Cell cultures
NIH3T3 cells that maintained a stable expression of the different Ras isoforms (in a pCEFL-KZ-AU5 vector) were Ras specificity in NF-jB activation O. Millán et al used following standard methods (JL Oliva et al., unpublished results) . In experiments of transfection with (kB) 3 ConA.Luc reporter gene (10 cm plates), the cells were cotransfected with the Ras vectors (1 mg of DNA) and the reporter (0.5 mg of DNA). Pharmacological suppression of NF-kB activation was achieved with 50 mg/ml of SN50, an inhibitor of the translocation to the nucleus, and 10 mm MG132, a proteasome inhibitor. MEK1 was inhibited with 10 mm PD98059. PI3-kinase was inhibited with 20 mm LY294002. Cells were preincubated for 5 h with SN50 and MG132 and for 30 min with the proteinkinase inhibitors prior to activation with TNFa.
Plasmid preparation and cell transfection
A (kB) 3 ConA.Luc plasmid construct, which contains three copies of the kB motif from the HIV LTR enhancer with the conalbumin A promoter, was used to measure kB transactivation capacity (Diaz-Guerra et al., 1996; Castrillo et al., 2000) . A ConA.Luc vector, lacking the kB tandem, was used as control. The b-galactosidase plasmid was used as a reference for efficiency of the transfection. Plasmids were purified using EndoFree Qiagen columns (Hilden, Germany). Cells were transfected with Superfect Transfection Reagent (Qiagen), following the instructions of the supplier.
Preparation of cytosolic and nuclear protein extracts
The cells were scrapped off the dishes (6 cm diameter) with PBS and after centrifugation were homogenized in 0.15 ml of ice-cold buffer A (10 mm HEPES, pH 7.9; 1 mm EDTA, 1 mm EGTA, 10 mm KCl, 1 mm dithiothreitol, 0.5 mm PMSF, 2 mg/ml tosyl-lysyl-chloromethane, 40 mg/ml aprotinin, 4 mg/ ml leupeptin, 5 mm NaF, 1 mm NaVO 4 , 10 mm Na 2 MoO 4 , 0.5% vol : vol Nonidet P-40). The extracts were centrifuged for 15 min at 8000 g and the supernatants were stored at À801C (soluble extracts). The pellets were resuspended in 200 ml of buffer A supplemented with 20% vol : vol glycerol and 0.4 m KCl, and vortexed for 30 min at 41C. The nuclear suspension was centrifuged in an Eppendorf centrifuge and the supernatant stored at À801C (nuclear extract).
Western blot analysis
The relative amounts of IKK1/2, p65, IkBa, P-S 32 -IkBa and GAPDH were determined in soluble extracts (Castrillo et al., 2000) . The levels of expression of Ras were determined with anti-AU5 mAb. Equal amounts of protein were size-fractionated in 10% SDS-PAGE, transferred to a PVDF membrane (Amersham) and after blocking with 5% nonfat dry milk, were incubated with the corresponding antibodies (1 : 1000). The blot was revealed after incubation with horseradish peroxidase conjugated IgG (1 : 2000) and following the ECL protocol (Amersham) as recommended. Different exposition times were performed for each blot to ensure the linearity of the band intensities. Densitometric analysis of the bands was carried out using a laser densitometer (Molecular Dynamics, Sunnyvale, CA, USA).
EMSAs
The oligonucleotide corresponding to the proximal kB motif of the murine NOS2 promoter (Xie et al., 1992; Castrillo et al., 2000) Binding assays of nuclear extracts were carried out with 5 Â 10 4 d.p.m. of the DNA probe as follows: 5 mg of nuclear protein extract were incubated for 30 min at 41C with the DNA and 1 mg/ml of poly(dI Á dC), 5% glycerol, 1 mm EDTA, 100 mm KCl, 5 mm MgCl 2 , 1 mm dithiothreitol and 10 mm Tris-HCl, pH 7.8, in a final volume of 20 ml. Samples were applied to a 6% polyacrylamide gel, which had been previously electrophoresed for 30 min at 100 V. Gels were run at 0.8 V/cm 2 in 45 mm Tris-borate, followed by transference to 3MM Whatman paper, drying under vacuum at 801C and quantification of the band intensities in an autoradiograph (Fuji Bas 1000). Specificity of the protein-DNA interaction was ensured by serial dilutions of the binding assay with an excess of unlabeled probe. Supershift assays were carried out after incubation at 41C for 30 min of the nuclear extracts with 2 mg of the anti-p50, p65 and c-Rel antibodies.
Measurement of IKK activity
Cells (10 7 ) were homogenized in ice-cold buffer A and centrifuged for 10 min in a microcentrifuge. The supernatant (1 ml) was precleared and the IKK complex was immunoprecipitated with 1 mg of anti-IKK2 Ab. After extensive washing of the immunoprecipitate with buffer A, the pellet was resuspended in kinase buffer (20 mm HEPES, pH 7.4; 0.1 mm EDTA, 100 mm NaCl, 1 mm DTT, 0.5 mm PMSF, 2 mg/ml aprotinin, 10 mg/ml leupeptin, 2 mg/ml TLCK, 5 mm NaF, 1 mm NaVO 4 , 10mm Na 2 MoO 4 and 10 mm okadaic acid). The kinase activity was assayed in 100 ml of buffer A containing 100 ng of immunoprecipitate, 50 mm [g-32 P]ATP (0.5 mCi), and using as substrate 200 ng of MBP. The reaction was stopped after 15 min of incubation and the incorporation of radioactivity into MBP was determined by liquid scintillation. The same protocol was used when the activity of IKK was determined by Western blot using antiphospho-IkBa(ser 32 ) Ab, except for the use of 1 mm MgATP instead of [g-32 P]ATP.
Evaluation of apoptosis
The percentage of apoptotic cells was determined using terminal deoxyribonucleotidyltransferase to incorporate fluorescein-12-dUTP into nuclei, following the manufacturer's protocol (TUNEL method, Roche). After TUNEL incubation, the cells were washed twice with PBS and analysed in a flow cytometer. DEVDase activity, mainly corresponding to caspases 3 and 7, was measured in cell extracts prepared in buffer A supplemented with 120 mm NaCl. After centrifugation of the cell lysate, the supernatant was used to measure the DEVDase using N-acetyl-DEVD-AFC as fluorogenic substrate and following the instructions of the supplier (Calbiochem). The linearity of the caspase assay was determined over a 30-min reaction period.
Statistical analysis
The data shown are the mean +s.d. of the indicated number of experiments. Statistical significance was estimated with Student's t-test for unpaired observations. A P value of less than 0.05 was considered significant. In studies of Western blot analysis, linear correlations between increasing amounts of protein and signal intensity were observed. 
